Home › Funds › Opaleye Management Inc. › CABA

Opaleye Management Inc. position in CABA

CABALETTA BIO INC · Health Care

Opaleye Management Inc. reported holding 3,863,800 shares of CABA (CABALETTA BIO INC) in its Q2 2026 13F filing — a position valued at US$12.0M, representing 1.09% of its reported portfolio and ranking #26 among its reported holdings. Opaleye Management Inc. has disclosed CABA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)3.86M sh
Reported value held$12.02M
Portfolio Weight1.09%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opaleye Management Inc.'s CABA position evolved

Opaleye Management Inc. first disclosed a stake in CABA in Q3 2025 at 808,882 shares (US$1.9M). The position peaked in Q2 2026 at 3,863,800 shares, worth US$12.0M. Across 4 filings, Opaleye Management Inc. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,863,800 shares valued at US$12.0M — an increase of 2,483,800 shares quarter over quarter.. Notable position changes include a 53% increase in Q1 2026 (shares rose 16% over the following quarter), a 180% increase in Q2 2026 (shares fell 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 808.88K $1.89M New
Q4 2025 900.00K $1.97M Add
Q1 2026 1.38M $3.71M Add
Q2 2026 3.86M $12.02M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CABA and 13F data

CABA (CABALETTA BIO INC) is a Health Care company. 37 other funds we track also report a position in CABA — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$53.6M), Cormorant Asset Management, LP (US$15.6M), SUPERSTRING CAPITAL MANAGEMENT LP (US$3.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CABA

All CABA fund holders →

FAQ

How long has Opaleye Management Inc. held CABA?

Opaleye Management Inc. has disclosed CABA holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Opaleye Management Inc.'s current position in CABA?

As of Q2 2026, Opaleye Management Inc. holds 3.86M shares of CABA (CABALETTA BIO INC), valued at $12.02M, representing 1.09% of its reported portfolio and ranking #26.

Has Opaleye Management Inc. been buying or selling CABA?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. increased its position in CABA. The position peaked in Q2 2026 at 3.86M shares.

Which other funds hold CABA?

Other major institutional holders of CABA include Bain Capital Life Sciences Investors, LLC, Cormorant Asset Management, LP, SUPERSTRING CAPITAL MANAGEMENT LP, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.